Trajenta

Showing 8 posts of 8 posts found.

Trajenta may reduce stroke damage

December 4, 2012
Research and Development, Sales and Marketing Boehringer, EMA, Trajenta, diabetes, linagliptin

Boehringer Ingelheim’s  diabetes drug Trajenta could one day be used to minimise the effects of brain damage following stroke. Scientists …

Trajenta added to insulin recommended in Europe

September 26, 2012
Sales and Marketing Boehringer Ingelheim, Trajenta, diabetes

The CHMP has recommended that Boehringer Ingelheim and Eli Liily and Co’s diabetes brand Trajenta should be approved as add-on …

Pharma calls for urgent change in German system

June 8, 2012
Sales and Marketing AMNOG, EFPIA, Germany, Trajenta, VFA

Europe’s pharma industry has called on the German government to re-think its approach to pricing, saying it is could cause …

Boehringer building image

Trajenta article lands Boehringer in hot water

March 19, 2012
Sales and Marketing ABPI Code, PMCPA, Trajenta, breach, diabetes

Boehringer Ingelheim has been publicly reprimanded for multiple breaches of the ABPI Code of Practice. In total the manufacturer fell …

Boehringer Ingelheim

Boehringer’s Trajenta launched in the UK

September 20, 2011
Sales and Marketing Boehringer, Trajenta, diabetes

Boehringer Ingelheim has launched its new diabetes drug Trajenta in the UK, with a price tag to match its rival …

Boehringer-Lilly's Trajenta

Boehringer-Lilly won’t launch Trajenta in Germany

September 5, 2011
Sales and Marketing Drug pricing, Germany, Tradjenta, Trajenta, price cuts

Boehringer Ingelheim and Lilly have decided not to launch their new diabetes drug Trajenta in Germany and say the country’s …

Boehringer - Lilly's Trajenta (linagliptin)

Boehringer-Lilly’s Trajenta wins European approval

August 26, 2011
Sales and Marketing Tradjenta, Trajenta, diabetes

Boehringer Ingelheim and Eli Lilly’s new type II diabetes drug Trajenta has been approved Europe. The European Commission backed Trajenta …

Boehringer Ingelheim Eli Lilly Trajenta linagliptin

CHMP backs Boehringer-Lilly diabetes drug Trajenta

June 27, 2011
Sales and Marketing Tradjenta, Trajenta, diabetes

Boehringer Ingelheim and Eli Lilly’s new type II diabetes drug Trajenta has been recommended for European approval. It was given …

Latest content